Middle East And Africa Hemp Source CBD Market Size & Outlook, 2026-2034
Middle East And Africa Hemp Source CBD Market Insights
- Deep Market Insights analysis indicates that the Middle East And Africa Hemp Source CBD Market size, which was USD 345.22 Million in 2025, is projected to attain USD 967.46 Million by 2034.
- The market is expected to register a CAGR of 12.15% over the period 2026–2034.
- In 2025, Hemp-derived CBD Distillate emerged as the dominant Type based on market size.
- Hemp-derived CBD Isolate is projected to register the fastest growth, positioning it as the most attractive Type segment over the forecast horizon.
![Middle East And Africa Hemp Source CBD Market Size, Share & Growth Analysis By [2034]](https://deepmarketinsights.com/uploads/charts/hemp-source-cbd-market-middle-east-and-africa--1370.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Middle East And Africa held 11.82% share of the global Hemp Source CBD Market size in 2025.
- United States is expected to remain the largest contributor to the global market size by 2034.
- By 2034, Saudi Arabia is anticipated to record the highest growth in Middle East and Africa, with the market size expected to reach USD 268.57 Million.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 345.22 Million |
| Market Size In 2034 | USD 967.46 Million |
| Largest segment | Hemp-derived CBD Distillate |
| Units | Revenue in USD Million |
| CAGR | 12.15% (2026-2034) |
| Segmnetation Covered | |
| Middle East and Africa |
|
| Type |
|
| Application |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Middle East And Africa Hemp Source CBD Market Country 2026-2034 (USD Million)
| Middle East and Africa | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Arab Emirates | XX.x | XX.x | XX.x | 142.09 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Saudi Arabia | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| South Africa | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Egypt | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Nigeria | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Turkey | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Middle East And Africa Hemp Source CBD Market Type 2026-2034 (USD Million)
| Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hemp-derived CBD Distillate | XX.x | XX.x | XX.x | 155.56 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hemp-derived CBD Isolate | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hemp-derived CBD Terpenes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Middle East And Africa Hemp Source CBD Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Personal Care and Cosmetics | XX.x | XX.x | XX.x | 140.95 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Food and Beverages | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Nutraceuticals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.